Bausch Health Companies (NYSE:BHC) Releases Quarterly Earnings Results, Misses Expectations By $0.44 EPS

Bausch Health Companies (NYSE:BHC) issued its quarterly earnings data on Wednesday. The company reported $1.21 EPS for the quarter, missing the consensus estimate of $1.65 by ($0.44), Zacks reports. Bausch Health Companies had a negative return on equity of 755.86% and a negative net margin of 1.88%. Bausch Health Companies updated its FY 2025 guidance to EPS.

Bausch Health Companies Stock Up 2.9 %

NYSE:BHC traded up $0.18 during mid-day trading on Wednesday, hitting $6.54. 2,885,751 shares of the company traded hands, compared to its average volume of 3,337,500. The stock’s fifty day moving average price is $7.39 and its 200-day moving average price is $7.47. Bausch Health Companies has a one year low of $3.96 and a one year high of $11.46. The firm has a market cap of $2.37 billion, a price-to-earnings ratio of -13.63, a price-to-earnings-growth ratio of 0.32 and a beta of 0.68.

Wall Street Analyst Weigh In

Several analysts recently commented on BHC shares. Royal Bank of Canada cut their price objective on Bausch Health Companies from $11.00 to $10.00 and set a “sector perform” rating for the company in a report on Thursday, January 30th. StockNews.com raised Bausch Health Companies from a “hold” rating to a “buy” rating in a report on Friday, October 25th. Finally, Jefferies Financial Group reaffirmed a “hold” rating and issued a $8.00 price objective (down previously from $12.00) on shares of Bausch Health Companies in a report on Thursday, February 6th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $7.42.

About Bausch Health Companies

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.